Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Steven Wang
Q&A
By Andrea Peirce, BA, Writer/Editor  |  Monday, December 17, 2012

By mid-December 2012, sunscreen products on store shelves in the United States must meet stricter labeling regulations. Dr. Wang answers key questions on this topic.

Pictured: Ming Li
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 14, 2012

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Lorenz Studer
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 11, 2012

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

Pictured: Ethel Law & Elizabeth Grahn
Announcement
By Media Staff  |  Monday, December 10, 2012

Memorial Sloan Kettering advanced practice nurses Elizabeth Grahn and Ethel Law have been recognized for their extraordinary achievements in education and research.

Pictured: Charles Sawyers
Announcement
By Media Staff  |  Saturday, December 8, 2012

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

Research
Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Pictured: 2012 Rock Stars of Science
Announcement
By Allyson Collins, MS, Science Writer/Editor  |  Thursday, December 6, 2012

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Pictured: Clifford Hudis
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, December 5, 2012

New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.

Feature
By Memorial Sloan Kettering  |  Monday, December 3, 2012

Memorial Sloan Kettering physicians and nurses take their knowledge and expertise overseas.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: Carol Brown
Video
By Memorial Sloan Kettering  |  Wednesday, November 28, 2012

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

Pictured: Michael Berger & David Solit
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 26, 2012

At Memorial Sloan Kettering, new technologies to study gene changes in cancer cells are accelerating the development and implementation of more-effective treatments.

Q&A
By Media Staff  |  Wednesday, November 21, 2012

Cancer patients use more blood and platelets than patients with any other illness. Memorial Sloan Kettering is always in need of blood donations – especially during the holiday season.

Center News

Stay Informed

Get the latest information about cancer care and research every month.